Sinusoidal obstruction syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* Endophlebitis in the terminal hepatic venule was first described by a pathologist from Prague in 1905.<ref name="pmid25755580">{{cite journal| author=Fan CQ, Crawford JM| title=Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). | journal=J Clin Exp Hepatol | year= 2014 | volume= 4 | issue= 4 | pages= 332-46 | pmid=25755580 | doi=10.1016/j.jceh.2014.10.002 | pmc=4298625 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25755580 }} </ref> | |||
* | |||
* This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page. | * This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page. | ||
* For an example of the overview section of the historical perspective page, click [[Chronic stable angina historical perspective#overview|here]]. | * For an example of the overview section of the historical perspective page, click [[Chronic stable angina historical perspective#overview|here]]. | ||
Revision as of 18:13, 3 January 2018
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome historical perspective |
|
FDA on Sinusoidal obstruction syndrome historical perspective |
|
CDC on Sinusoidal obstruction syndrome historical perspective |
|
Sinusoidal obstruction syndrome historical perspective in the news |
|
Blogs on Sinusoidal obstruction syndrome historical perspective |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Historical Perspective
- Endophlebitis in the terminal hepatic venule was first described by a pathologist from Prague in 1905.[1]
- This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page.
- For an example of the overview section of the historical perspective page, click here.
Template
- First Sentence:
- [Disease name] was first discovered by [scientist] in [year] during/following [event].
- OR
- [Disease name] was first described by [scientist] in [year].
- Examples:
- Example 1:Shigella was first discovered by Dr. Kiyoshi Shiga following a bacillary dysentery outbreak in Japan in 1896.
- Example 2: Melanoma was first described by Hippocrates in the 5th century BC.
- Additional Sentences:
- Additional Sentence 1: In [year], the first [event] occurred/was first reported following/during [event].
- Additional Sentence 2: In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
- Additional Sentence 3: There have been several outbreaks of [disease] which are summarized below.
- Additional Sentence 4: [Disease name] was first described in [year] by [scientist].
- Additional Sentence 5: [Risk factor or cause] was first discovered to be associated with [disease] in [year].
- Additional Sentence 6: In [year], [scientist] was the first to discover the association between [risk factor] and development of [disease].
- Additional Sentence 7: In [year], [gene] mutations were first identified in the pathogenesis of [disease].
- Examples:
- Example 1: In 1918, the first major human influenza pandemic occurred.
- Example 2: In 2003, human-to-human transmission of avian influenza was first reported during the influenza A H5N1 outbreaks in Southeast and Central Asia.
- Example 3: In 1978, the first cell-cytotoxicity assay was developed by Te-Wen Chang to diagnose C. difficile infection based on fecal toxins A and B.
- Example 4: There have been several outbreaks of avian influenza which are summarized below.
- Example 5: In 1956, Henry Lancaster, an Australian mathematician, was the first to discover the association between UV radiation exposure and development of melanoma.
- Example 6: In 2003, BRAF mutations were first identified in the pathogenesis of melanoma.
References
- ↑ Fan CQ, Crawford JM (2014). "Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)". J Clin Exp Hepatol. 4 (4): 332–46. doi:10.1016/j.jceh.2014.10.002. PMC 4298625. PMID 25755580.